< Previous Page
Ameridose strongly objected to the allegations and said in its defamation lawsuit that the Novation auditors were unqualified and made false and misleading statements. Ameridose also said it had been audited in recent years by several other organizations that determined its quality control system "meets or exceeds their high quality standards." Ameridose is regulated by the U.S. Food and Drug Administration.
The lawsuit ended in a confidential settlement Sept. 24.
CDC: Meningitis cases reach 170, 14 people die
The government says 170 people now have been sickened in the meningitis outbreak linked to tainted steroid shots, and 14 of them have died.
Idaho becomes the 11th state to report at least one illness. The others are Florida, Indiana, Maryland, Michigan, Minnesota, New Jersey, North Carolina, Ohio, Tennessee and Virginia.
The Centers for Disease Control and Prevention updated the count Thursday, showing 33 more cases and two additional deaths reported to the agency in the past day. The outbreak of rare fungal meningitis has been linked to steroid shots for back pain. A specialty pharmacy in Massachusetts has recalled the steroid that was sent to clinics in 23 states, as well as everything else it makes.
![]() |
Join the Discussion |
![]() |
Post a Comment |
Paven, the Ameridose and New England Compounding Center spokesman, said Wednesday in his email that the "suit involved contractual commercial issues between the companies that have since been resolved."
A statement from Novation said that while it "vigorously disputed each and every claim made in the lawsuit, the parties ultimately agreed to settle the lawsuit."
-
Palace reveals some of Kate’s baby plans
Published Jun 19, 2013 03:20:02PM -
Unlicensed Utah midwife charged in newborn’s death
Published Jun 19, 2013 03:16:03PM -
Your town in brief: A world of fun
Published Jun 19, 2013 03:12:03PM -
Your town in brief: Unscripted comedy
Published Jun 19, 2013 03:10:02PM
Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.






